GPCR
STRUCTURE SP ADS (GPCR)
NASDAQ
$45.60+$0.09 (+0.20%)
Price as of Jun 23, 2026 5:58 PM EDT
  • $3.2B
    Market Cap
  • 105.93%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-225.3M
+107.01%
-108.8M
+55.22%
-70.1M
N/A
Depreciation and Amortization Expense
1.3M
+34.38%
992,000
+236.27%
295,000
N/A
Total Operating Expenses
176.6M
+11.59%
158.2M
+53.96%
102.8M
N/A
Operating Profit
-176.6M
+11.59%
-158.2M
+53.96%
-102.8M
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
N/A
N/A
N/A
N/A
N/A
N/A
Income before Taxes
-140.7M
+15.11%
-122.2M
+36.73%
-89.4M
N/A
Income Taxes
515,000
+66.13%
310,000
+31.36%
236,000
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-141.2M
+15.24%
-122.5M
+36.72%
-89.6M
N/A
Net Income from Continuing Operations Applicable to Common
-140.7M
+15.11%
-122.2M
+36.37%
-89.6M
N/A
Basic EPS and Net Income
-0.80
+2.56%
-0.78
-3.70%
-0.81
N/A
Diluted EPS and Net Income
-0.80
+2.56%
-0.78
-3.70%
-0.81
N/A
Basic Weighted Average Shares
177.6M
+12.46%
157.9M
+43.31%
110.2M
N/A
Diluted Weighted Average Shares
177.6M
+12.46%
157.9M
+43.31%
110.2M
N/A
Balance Sheet
Cash and Cash Equivalents
799.6M
+371.73%
169.5M
+30.60%
129.8M
N/A
Short-Term Investments
646.6M
-9.44%
714.0M
+111.54%
337.5M
N/A
Cash and Cash Equivalents and Short-Term Investments
1.4B
+63.69%
883.5M
+89.06%
467.3M
N/A
Total Current Assets
1.6B
+76.20%
891.2M
+88.17%
473.6M
N/A
Accumulated Depreciation
3.0M
+81.48%
1.6M
+154.04%
644,000
N/A
Property and Plant and Equipment and Net
6.7M
+91.29%
3.5M
+7.74%
3.2M
N/A
Total Long-Term Assets
717,000
-85.96%
5.1M
+11,246.67%
45,000
N/A
Total Assets
1.6B
+75.34%
903.3M
+87.41%
482.0M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
63.3M
+75.69%
36.0M
+45.60%
24.7M
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
647,000
+114.24%
302,000
+1.34%
298,000
N/A
Total Liabilities
67.5M
+75.49%
38.5M
+32.48%
29.1M
N/A
Retained Earnings
-470.3M
+42.91%
-329.1M
+59.31%
-206.6M
N/A
Total Stockholders Equity
1.5B
+75.34%
864.8M
+90.93%
453.0M
N/A
Total Shares Outstanding
212.5M
+23.65%
171.9M
+23.44%
139.2M
N/A
Cash Flow
Cash from Operating Activities
-222.2M
+90.51%
-116.6M
+46.73%
-79.5M
N/A
Capital Expenditures
3.6M
+180.16%
1.3M
-40.47%
2.2M
N/A
Cash from Investing Activities
89.8M
+125.02%
-358.9M
+33.75%
-268.3M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
762.5M
+47.99%
515.3M
+14.11%
451.5M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-11.35%
-35.81%
-17.69%
N/A
N/A
N/A
Return on Equity
-11.86%
-36.22%
-18.60%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
24.81
+0.29%
24.74
N/A
N/A
N/A
Cash Ratio
12.64
+168.50%
4.71
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow